2-189560748-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014585.6(SLC40A1):​c.*1130A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0828 in 152,620 control chromosomes in the GnomAD database, including 1,298 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.083 ( 1298 hom., cov: 33)
Exomes 𝑓: 0.0069 ( 0 hom. )

Consequence

SLC40A1
NM_014585.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.308

Publications

4 publications found
Variant links:
Genes affected
SLC40A1 (HGNC:10909): (solute carrier family 40 member 1) The protein encoded by this gene is a cell membrane protein that may be involved in iron export from duodenal epithelial cells. Defects in this gene are a cause of hemochromatosis type 4 (HFE4). [provided by RefSeq, Jul 2008]
SLC40A1 Gene-Disease associations (from GenCC):
  • hemochromatosis type 4
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 2-189560748-T-C is Benign according to our data. Variant chr2-189560748-T-C is described in ClinVar as [Benign]. Clinvar id is 333153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.234 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC40A1NM_014585.6 linkc.*1130A>G 3_prime_UTR_variant Exon 8 of 8 ENST00000261024.7 NP_055400.1 Q9NP59
SLC40A1XM_047444066.1 linkc.*1130A>G 3_prime_UTR_variant Exon 8 of 8 XP_047300022.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC40A1ENST00000261024.7 linkc.*1130A>G 3_prime_UTR_variant Exon 8 of 8 1 NM_014585.6 ENSP00000261024.3 Q9NP59

Frequencies

GnomAD3 genomes
AF:
0.0829
AC:
12600
AN:
152070
Hom.:
1296
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.237
Gnomad AMI
AF:
0.0428
Gnomad AMR
AF:
0.0514
Gnomad ASJ
AF:
0.0758
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0254
Gnomad FIN
AF:
0.0141
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0180
Gnomad OTH
AF:
0.0817
GnomAD4 exome
AF:
0.00694
AC:
3
AN:
432
Hom.:
0
Cov.:
0
AF XY:
0.00385
AC XY:
1
AN XY:
260
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00704
AC:
3
AN:
426
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
2
Other (OTH)
AF:
0.00
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0830
AC:
12631
AN:
152188
Hom.:
1298
Cov.:
33
AF XY:
0.0804
AC XY:
5980
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.238
AC:
9853
AN:
41480
American (AMR)
AF:
0.0513
AC:
784
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0758
AC:
263
AN:
3470
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5180
South Asian (SAS)
AF:
0.0250
AC:
121
AN:
4832
European-Finnish (FIN)
AF:
0.0141
AC:
150
AN:
10606
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0180
AC:
1225
AN:
68016
Other (OTH)
AF:
0.0803
AC:
170
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
521
1041
1562
2082
2603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0598
Hom.:
1244
Bravo
AF:
0.0947
Asia WGS
AF:
0.0220
AC:
78
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hemochromatosis type 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
13
DANN
Benign
0.84
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11539983; hg19: chr2-190425474; API